Syros
IPOCambridge, United States · Founded 2012
- Headquarters
- Cambridge, Massachusetts
- Founded
- 2012
- Business Model
- B2B
- Website
- syros.com
- Last Round
- Venture RoundDec 2020
- Rounds
- 4
About
Syros Pharmaceuticals (NASDAQ: SYRS) is a biopharmaceutical company co-founded by Flagship Pioneering that is advancing a new wave of medicines to control the expression of genes. The company's platform represents the first dedicated effort to systematically identify disease-causing alterations in gene expression and develop therapies that modulate gene activity for diseases resistant to traditional genomics approaches. Syros is focused on developing new standards of care for the frontline treatment of patients with hematologic malignancies and other cancers.
Summary
Syros is a Biotech company based in Cambridge, United States, founded in 2012. Its most recent funding was a Venture Round round in Dec 2020. Investors include Polaris Partners, ARCH Venture Partners and Flagship Pioneering.
Funding History
Dec 2020
Sign up to see all 5 rounds
Series A through Venture Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/syros"><img src="https://indexed.vc/api/badge/company/syros" alt="Syros on Indexed.vc" width="260" height="76" /></a>